These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9310470)

  • 1. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients.
    Lieberman J; Skolnik PR; Parkerson GR; Fabry JA; Landry B; Bethel J; Kagan J
    Blood; 1997 Sep; 90(6):2196-206. PubMed ID: 9310470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
    Cao H; Kanki P; Sankalé JL; Dieng-Sarr A; Mazzara GP; Kalams SA; Korber B; Mboup S; Walker BD
    J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.
    Koenig S; Conley AJ; Brewah YA; Jones GM; Leath S; Boots LJ; Davey V; Pantaleo G; Demarest JF; Carter C
    Nat Med; 1995 Apr; 1(4):330-6. PubMed ID: 7585062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.
    Koeppe JR; Campbell TB; Rapaport EL; Wilson CC
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):140-8. PubMed ID: 16394844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    Altfeld MA; Trocha A; Eldridge RL; Rosenberg ES; Phillips MN; Addo MM; Sekaly RP; Kalams SA; Burchett SA; McIntosh K; Walker BD; Goulder PJ
    J Virol; 2000 Sep; 74(18):8541-9. PubMed ID: 10954555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.
    Gahéry-Ségard H; Pialoux G; Charmeteau B; Sermet S; Poncelet H; Raux M; Tartar A; Lévy JP; Gras-Masse H; Guillet JG
    J Virol; 2000 Feb; 74(4):1694-703. PubMed ID: 10644339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death.
    Aladdin H; Ullum H; Lepri AC; Leffers H; Katzenstein T; Gerstoft J; Gjedde SB; Phillips AN; Skinhøj P; Pedersen BK
    Scand J Immunol; 1999 Aug; 50(2):223-7. PubMed ID: 10447929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocytes recognize structurally diverse, clade-specific and cross-reactive peptides in human immunodeficiency virus type-1 gag through HLA-B53.
    Dorrell L; Willcox BE; Jones EY; Gillespie G; Njai H; Sabally S; Jaye A; DeGleria K; Rostron T; Lepin E; McMichael A; Whittle H; Rowland-Jones S
    Eur J Immunol; 2001 Jun; 31(6):1747-56. PubMed ID: 11385619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
    Lubaki MN; Egan MA; Siliciano RF; Weinhold KJ; Bollinger RC
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1427-31. PubMed ID: 7888197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy.
    Ferrari G; Berend C; Ottinger J; Dodge R; Bartlett J; Toso J; Moody D; Tartaglia J; Cox WI; Paoletti E; Weinhold KJ
    Blood; 1997 Sep; 90(6):2406-16. PubMed ID: 9310492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.
    Wang S; Zhuang Y; Zhai S; Zhao S; Kang W; Li X; Yu XG; Walker BD; Altfeld MA; Sun Y
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):780-7. PubMed ID: 16910834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
    Kostense S; Ogg GS; Manting EH; Gillespie G; Joling J; Vandenberghe K; Veenhof EZ; van Baarle D; Jurriaans S; Klein MR; Miedema F
    Eur J Immunol; 2001 Mar; 31(3):677-86. PubMed ID: 11241270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
    J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.